Product logins

Find logins to all Clarivate products below.


Trauma Devices | Market Insights | Asia Pacific (Supplemental) | 2024

In recent years, the Asia Pacific trauma device market has been negatively impacted by various events, including the COVID-19 pandemic, which diminished procedure volumes at the time, as well as the introduction of the volume-based procurement policy by the Chinese government, which is placing downward pressure on ASPs in the country. Nonetheless, favorable demographics and rising adoption of innovative devices will continue to support overall market growth through 2032.

This Medtech 360 Report provides high-level market metrics for trauma devices in the Asia Pacific region, including country-level data for major countries and aggregate data for the rest of the Asia Pacific region from 2019 through 2032.

Related Medtech Insights Reports

Report
Neurovascular Devices – Market Insights – Asia Pacific
The Asia Pacific neurovascular device market will grow strongly through the forecast period, driven by various factors such as rising procedure volumes, product launches, and increasing…
Report
Large-Joint Reconstructive Implants – Market Insights – Asia Pacific
The Asia Pacific large-joint reconstructive implant market is experiencing moderate growth driven by an increasing number of elective procedures, a rising elderly population affected by arthritis…
Report
Gynecological Devices – Market Insights – Asia Pacific
Driven by the rising prevalence of gynecological diseases and aging population in this region, the Asia Pacific gynecological device market will continue to witness modest growth through 2034…
Report
Biosurgical Agents – Market Insights – Asia Pacific (Supplemental)
The biosurgical agent market in the Asia-Pacific will experience modest growth through 2033. This growth will be fueled by an increasing number of surgical interventions that require biosurgical…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Asia Pacific
The GI endoscopy device market will continue to grow moderately throughout the forecast period, supported by the high incidence of gastric cancer and CRC cases in the region. Growth will be…